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Neutrophils are produced in the bone marrow from stem cells that proliferate and differentiate to mature
neutrophils fully equipped with an armory of granules. These contain proteins that enable the neutrophil to
deliver lethal hits against microorganisms, but also to cause great tissue damage. Neutrophils circulate in
the blood as dormant cells. At sites of infection, endothelial cells capture bypassing neutrophils and guide
them through the endothelial cell lining whereby the neutrophils are activated and tuned for the subsequent
interaction with microbes. Once in tissues, neutrophils kill microorganisms by microbicidal agents liberated
fromgranules or generated bymetabolic activation. As a final act, neutrophils can extrude stands of DNAwith
bactericidal proteins attached that act as extracellular traps for microorganisms.Introduction
Neutrophils are indispensable for defense against intruding
microorganisms. They are generated in great number in the
bone marrow and circulate in blood for a few hours. If microor-
ganisms have successfully overcome the physical barriers
provided by the skin and mucus membranes and gained access
to tissues, signals generated by microbes and resident macro-
phages at sites of infection activate the local endothelial cells,
which capture bypassing neutrophils and guide them across
the endothelial cell lining. Products generated by live microor-
ganisms and by their interaction with soluble proteins that recog-
nize microorganisms guide neutrophils toward the microbes,
which are taken up by phagocytosis and exposed to high
concentrations of bactericidal substances in the phagocytic
vacuole. Neutrophils in tissues produce agents that attract addi-
tional neutrophils and macrophages and T cells and regulate
their activity. This review will focus on the mechanisms that
control the generation of neutrophils and the formation of their
distinct subsets of granules, the molecules that are involved in
recruitment of neutrophils to sites of infection in the systemic
circulation, the generation of bactericidal extracellular traps,
and the resolution of inflammation.
Production of Neutrophils
Production of neutrophils is quantitatively the major activity of
the bone marrow, where approximately two-thirds of the
blood-cell-forming activity (hematopoiesis) is devoted to myelo-
poiesis, the term used for the collective production ofmonocytes
and granulocytes. Hematopoietic stem cells localize to niches
provided by osteoblasts and characterized by little blood flow
and low oxygen tension, while the more mature and actively
dividing stem cells reside closer to the abluminal side of the
sinusoids, the special vascular structure of the bone marrow
(Winkler et al., 2010). b1-integrins such as a4b1, a6b1, and a9b1
are expressed on hematopoietic stem cells and interact with
osteoblasts in the stem cell niches and with the extracellular
matrix (Qian et al., 2006, 2007; Schreiber et al., 2009; Grassinger
et al., 2009). The chemokine receptor CXCR4 is essential for
homing of stem cells and more mature neutrophils to the bone
marrow (Lapidot and Kollet, 2002). CXCR4 binds CXCL12(former stromal derived factor 1 [SDF1]), which is expressed by
bone marrow stromal cells, including both osteoblasts and
vascular endothelial cells in the bonemarrow (Lapidot andKollet,
2002).
The production of neutrophils is extensive in steady state with
1 to 2 3 1011 cells being generated per day in a normal adult
human. G-CSF (granulocyte colony stimulating factor) is essen-
tial for tuning the production of neutrophils to meet the increased
needs during infections, but G-CSF is not absolutely required for
granulocytopoiesis because G-CSF null mice have approxi-
mately 25% residual granulocytopoiesis and generate fully
mature neutrophils (Lieschke et al., 1994). The production of
neutrophil is largely regulated by the rate of apoptosis of neutro-
phils in tissues. When macrophages and dendritic cells phago-
cytose apoptotic neutrophils in tissues, their production of
interleukin 23 (IL-23) is reduced (Ley et al., 2006; Stark et al.,
2005; von Vietinghoff and Ley, 2009). IL-23 stimulates produc-
tion of interleukin 17A (IL-17A) by specialized T cells collectively
called neutrophil regulatory T cells, which are largely localized in
the mesenteric lymph nodes. These are largely gamma-delta
T cells and NK-like T cells (Ley et al., 2006). IL-17A is an impor-
tant stimulus for G-CSF production (Schwarzenberger et al.,
2000). Hence, production of G-CSF is reduced when the number
of neutrophils in tissues increases.
Release of Neutrophils from Bone Marrow
Asmentioned, CXCR4 plays a crucial role for maintaining neutro-
phils in the bonemarrow. Deletion of CXCR4 causes a shift in the
pool of mature neutrophils from bone marrow to circulation
without affecting the life-span of circulating neutrophils (Eash
et al., 2009). Conversely, mutations of CXCR4 that result in
increased signaling result in the clinical syndrome WHIM (warts,
hypogammaglobulinemia, infections, myelokathexis) character-
ized by deficiency of neutrophils in circulation and by increased
accumulation of mature neutrophils in the bonemarrow (Hernan-
dez et al., 2003). CXCR2 is another cytokine receptor expressed
onmyeloid cells. Its ligands, CXCL1 andCXCL2 (KC, andGrob or
MIP-2, respectively), are expressed by bone marrow endothelial
cells (Eash et al., 2010). Deletion of CXCR2 also causes a myelo-
kathexis phenotype with retention of mature neutrophils in theImmunity 33, November 24, 2010 ª2010 Elsevier Inc. 657
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Figure 1. Granulocytopoiesis in the Bone Marrow
Stem cells localize to niches provided by osteoblasts and endothelial cells. The balance between PU.1 and C/EBPa and Gfi-1 expression determines the differ-
entiation into the granulocytic or the monocytic pathways. The different subsets of granules (azurophil (red), specific granules (green), and gelatinase granules
(yellow) and secretory vesicles (empty) are formed sequentially during maturation from promyelocytes, determined by the expression of transcription factors indi-
cated on the top of the figure. Retention and release of cells is determined by the balance between CXCR4 (favoring retention) and CXCR2 (favoring release) and
their ligands SDF-1, and KC andGrob, respectively. G-CSF stimulates neutrophil release directly by effects on the neutrophil and indirectly by reducing the SDF-1
expression and enhancing the expression of Grob on endothelial cells.
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CXCR4 gives a phenotype similar to the CXCR4 deletion, i.e.,
inability to retain neutrophils in the bone marrow pool (Eash
et al., 2010). Thus, CXCR4 is necessary for maintaining the
neutrophil bone marrow pool ready for immediate release.
Release may be effectuated by signals through CXCR2,
G-CSFR or Toll-like receptors, all of which appear late during
neutrophil maturation in the bone marrow (Theilgaard-Mo¨nch
et al., 2005a). Stimulation of these receptors does not cause
additional neutrophil release from the bone marrow when
CXCR4 is absent, demonstrating the fundamental role of
CXCR4 signaling for homing of both immature and mature
neutrophils in the bone marrow (Eash et al., 2009; Figure 1).
The expression of SDF-1 by bone marrow endothelial cells is
downregulated by G-CSF, whereas G-CSF upregulates their
expression of KC and Grob, thus tilting the CCXR4- CXCR2
signaling in favor of CXCR2 and neutrophil release (Christopher
et al., 2009; Eash et al., 2010) (Figure 1).
Terminal Granulocytopoiesis
Terminal granulocytopoiesis describes the production of mature
granulocytes from committed progenitors. C/EBPa (CCAAT/
enhancer binding protein a) and PU.1 are both essential tran-
scription factors necessary for terminal granulocytopoiesis.
PU.1 is absolutely required for myeloid lineage commitment
(Nerlov and Graf, 1998; Iwasaki et al., 2005). The subsequent
decision between granulocyte and monocyte commitment is
determined by the balance between C/EBPa and PU.1 (Reddy
et al., 2002; Dahl et al., 2003; Laslo et al., 2006). High expression
of PU.1 drives monocytic differentiation, whereas C/EBPa is
absolutely required for granulocytopoiesis (Zhang et al., 1997;
Radomska et al., 1998), but granulocytopoiesis can be rescued
by C/EBPb in C/EBPa-deficient myelopoiesis stimulated by
IL-3 and GM-CSF (granulocyte-monocyte colony stimulating
factor) (Hirai et al., 2006), and C/EBPb is required for accelerated
granulocytopoiesis in response to fungal infections (Hirai et al.,
2006). MicroRNA 223 is an essential target for C/EBPa, which658 Immunity 33, November 24, 2010 ª2010 Elsevier Inc.displaces NFI-A from the miR223 promoter (Fazi et al., 2005),
allowing for subsequent granulocytic differentiation, in part by
downregulating the cell-cycle regulator E2F1 (Pulikkan et al.,
2010), which is also inhibited directly by C/EBPa (D’Alo’ et al.,
2003). In accordance, miR-223-deficient mice have double
production of neutrophils (Johnnidis et al., 2008). Recently, the
NF-kB p50 subunit has been shown to activate C/EBPa expres-
sion, both alone and more so in complex with C/EBPa itself,
resulting in enhanced G-CSF-induced granulocytopoiesis
in vivo, thus illustrating that this factor that is critical for mediating
inflammatory responses also regulates early granulocytopoiesis
(Wang et al., 2009).
A transcription factor normally expressed during lymphopoie-
sis, Lef-1 (lymphoid enhancer-binding factor-1), has been
suggested to regulate C/EBPa expression, and failure to express
Lef1 has been proposed as a unifying mechanism for severe
congenital neutropenia (Skokowa et al., 2006), caused by muta-
tions in the neutrophil elastase gene (Dale et al., 2000) and the
HAX1 gene (Klein et al., 2007). Although the mechanism for
this is not entirely clear, studies of PFAAP5, a protein identified
by 2-yeast hybrid screening with Lef-1 and elastase as baits,
may provide some clues (Salipante et al., 2009).
The transcription factor Gfi-1 (growth factor independent-1) is
necessary for neutrophil differentiation (Karsunky et al., 2002;
Hock et al., 2003). Gfi-1 is upregulated during stem cell commit-
ment to the granulocytic lineage (Velu et al., 2009). Upregulation
of Gfi-1 represses genes encoding HoxA9, Meis1, and Pbx1,
allowing for progression of differentiation (Horman et al., 2009),
and restricts the proliferation of stem cells (Hock et al., 2004).
Gfi-1 has additional effects on granulocytopoiesis by repressing
expression of Egr2 (early growth response-2) (Laslo et al., 2006),
a monocyte-promoting transcription factor, and Csf1 (Zarebski
et al., 2008), the gene coding for the monocytopoietic cytokine
CSF-1 (colony-stimulating factor 1). The effect of Gfi-1 is at least
partially mediated by repression of miR21 and miR196b (Velu
et al., 2009) which have promonocytopoietic and antigranulocy-
topoietic activities, respectively, in agreement with the effects
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et al., 2003). Mutations of Gfi-1 affecting its DNA binding site
are responsible for some cases of severe congenital neutropenia
(Person et al., 2003). The phenotype can be reproduced in mice.
This has revealed that the N382S Gfi-1 mutation results in block
of granulocytopoiesis because of overexpression of Csf-1. This
block is lifted by removal of Csf-1 (Zarebski et al., 2008).
The further differentiation beyond promyelocytes is regulated
by several transcription factors. C/EBP3 becomes expressed
at the myelocyte stage (Morosetti et al., 1997; Yamanaka et al.,
1997a, 1997b; Bjerregaard et al., 2003). C/EBP3 is required for
transcription of granule proteins at the myelocyte stage and
beyond, as evidenced by C/EBP3 gene-targeted mice (Yama-
naka et al., 1997a; Lekstrom-Himes and Xanthopoulos, 1999).
Mutations of C/EBP3 leading to nonexpression of the protein
account for some cases of the rare condition termed specific
granule deficiency (Gombart et al., 2001). Interaction with Gfi-1
may be essential for full activity of C/EBP3 (Khanna-Gupta
et al., 2007), although Gfi-1 expression is at a nadir when
C/EBP3 expression is at its peak (Bjerregaard et al., 2003). The
transition from promyelocyte into myelocyte is associated with
exit from cell cycle (Klausen et al., 2004). This is in part regulated
by C/EBP3, which binds Rb protein and E2F1 (Gery et al., 2004)
and represses their transactivating effect on genes that drive the
cell cycle. This effect, combined with the aforementioned effect
of miR223 on E2F, may explain the exit from cell cycle during this
stage ofmyelopoiesis. Expression of PU.1, essential for the initial
commitment to myelopoiesis, increases during maturation from
the promyelocyte stage, and its coactivator c-jun and its dimer-
ization partner c-fos both increase in myelocytes and metamye-
locytes (Bjerregaard et al., 2003). Accordingly, PU.1-deficient
mice demonstrate defects in terminal granulocytic development
in addition to the deficiency of committed stem cells. Whereas
C/EBPa expression gradually diminishes from the myeloblast
stage and up, and C/EBP3 peaks at the myelocyte-metamyelo-
cyte stage, C/EBPb, C/EBPg, C/EBPd, and C/EBPz all increase
from the metamyelocyte stage and on during maturation (Bjerre-
gaard et al., 2003). As the C/EBPs form both homodimers and
heterodimers and their activity is further regulated by phosphor-
ylation (Chumakov et al., 2007), they provide basis for a highly
individualized expression of granule proteins during terminal
granulocytic differentiation.
Formation of Granules and of Granule Proteins
Granules, the hallmark of granulocytes (eosinophils, basophils,
and neutrophils) are stores of proteins that can kill microbes
and digest tissues. Appearance of granules marks the transition
from myeloblast to promyelocyte and formation of granules
continues until the segmented stage of maturation is reached.
Granules may be filled passively by bulk flow of proteins coming
from the more proximal Golgi compartments. In agreement with
this, a variety of proteins that are constitutively secreted by the
liver, but also produced by neutrophil precursors, have been
identified as genuine granule proteins of the human neutrophil
such as haptoglobin (Theilgaard-Mo¨nch et al., 2006a), a1-acid
glycoprotein (Theilgaard-Mo¨nch et al., 2005b), and a1-antitryp-
sin (Johansson et al., 2001). However, not all granule proteins
are stored with equal efficiency. Lysozyme, an antibacterial
protein, is made by neutrophil precursors from the early promye-locyte and up to band cells (Lollike et al., 1995), and most newly
formed lysozyme is spilled out of the cells, while a-defensins are
efficiently withheld when formed in promyelocytes, but largely
spilled out when formed in the more mature myelocytes, indi-
cating that some selectivity does exist in the routing between
constitutive secretion and diversion to storage in granules
(Arnljots et al., 1998). Considering the size of the myeloid
compartment in the bone marrow, this is potentially a major
organ for secretion of proteins that are not efficiently targeted
to granules such as lysozyme and the cathelicidin antimicrobial
protein hCAP-18 (whose C-terminal part is known as LL-37),
both of which are found in high amounts in plasma (Lollike
et al., 1995; Sørensen et al., 1999).
Neutrophil granules are classified into three distinct subsets
basedon the presenceof characteristic granule proteins: primary
(azurophil) granules (myeloperoxidase [MPO]), secondary
(specific) granules (lactoferrin), and tertiary (gelatinase granules)
(gelatinase). These are formed sequentially during granulocytic
differentiation in the bonemarrow i.e., at the promyelocyte stage,
the myelocyte-metamyelocyte stage, and the band cell stage
(Borregaard et al., 1995; Borregaard and Cowland, 1997). This
distinction is operative because it not only reflects differences
in content of granules (Lominadze et al., 2005), but also differ-
ences in their mobilization with the granules formed latest being
the ones to be released earliest (Borregaard and Cowland,
1997).The distinction is, however, artificial because other marker
proteins identify subsets of granules that are formedat somewhat
different stages of differentiation than the classical three granule
subtypes (Faurschou et al., 2002; Rørvig et al., 2009; Udby et al.,
2002). The heterogeneity of neutrophil granules is best compre-
hended by assuming that granules are formed constitutively
from the early promyelocyte and up until the segmented stage
in the bone marrow and filled with proteins, synthesized when
the granules are formed. Because the windows of expression of
the individual granule proteins are highly divergent, granules
formed at different stages during maturation carry a different
cargo of matrix and membrane proteins. We have named this
mechanism for explaining granule heterogeneity ‘‘targeting by
timing of biosynthesis’’ (Le Cabec et al., 1996). Proteins synthe-
sized in neutrophils after exit from the bone marrow do not
seem to be packed in granules (Theilgaard-Mo¨nch et al., 2004;
Lapinet et al., 2000), but themechanisms for initiation and cessa-
tion of granule formation are not known.
Profiling the gene expression duringmyelopoiesis in relation to
stage of maturity of the cells has consequently allowed us to
confirm the relationship between gene expression of known
granule proteins and their granule localization (Theilgaard-
Mo¨nch et al., 2005a). It has further permitted us to predict the
localization of proteins not previously known to be granule
proteins of neutrophils and confirm their localization, e.g., hapto-
globin (Theilgaard-Mo¨nch et al., 2006a), pentraxin 3 (Jaillon
et al., 2007), arginase 1 (Jacobsen et al., 2007), and ficolin 1
(Rørvig et al., 2009).
Secretory Vesicles
The view of granules as storage organelles for proteins to be
liberated into phagosomes or outside the cell changed by the
discovery that the membrane components of the NADPH
oxidase, now known as the p22phox-gp91phox complex, isImmunity 33, November 24, 2010 ª2010 Elsevier Inc. 659
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Figure 2. Neutrophils in Tissues
Neutrophils are captured by endothelial cell P-se-
lectins. Bonds between P-Selectin and E-selectin
on endothelial cells and PSGL-1, L-selectin, ESL-
1, and CD44 on neutrophils mediate rolling and
activation of the neutrophil integrins, which
interact with ICAMs expressed on endothelial
cells. The trans-endothelial migration is either par-
acellular or transcellular. The tight junctions are
loosened by neutrophils that present alternative
binding partners PECAM-1, JAM-A, LFA-1, and
Mac-1, thus unzipping the tight junctions and
zipping themselves between the endothelial cells
to mediate paracellular migration. In transcellular
migration, transmigratory cups high in ICAM-1
and VCAM-1 capture crawling neutrophils that
then make their way through the cells. Once out
in tissues, a burst of transcriptional activity in
part mediated by local G-CSF production initiates
generation of cytokines by neutrophils. The
neutrophils phagocytose microorganisms and de-
granulate and may then either undergo apoptosis
or netosis. Uptake of apoptotic neutrophils by
macrophages downmodulates the production of
IL-23. Thereby, less IL-17 is generated from
T cells. Hence, less G-CSF is produced by fibro-
blast and endothelial cells to stimulate the neutro-
phil production in the bone marrow. Lipid media-
tors, lipoxins, resolvins, and protectins are
generated through sequential steps involving
neutrophils, endothelial cells, and macrophages.
They downmodulate neutrophil activation and
endothelial cell activation while enhancing uptake
of apoptotic cells by macrophages.
Immunity
Reviewlocated in the membrane of specific granules and becomes
incorporated into the surface membrane during activation of
neutrophils (Borregaard et al., 1983; Borregaard and Tauber,
1984). This was further expanded when secretory vesicles
were discovered as storage organelles of membrane proteins
wrapped around a matrix of plasma proteins (Borregaard et al.,
1992). They are created by endocytosis during the late matura-
tion of neutrophils in the bone marrow since they contain
membrane proteins whose genes are transcribed at the band
and segmented stage (Borregaard et al., 2007; Theilgaard-
Mo¨nch et al., 2006b), including the marker protein of secretory
vesicles, CD35 (Sengeløv et al., 1994). Secretory vesicles incor-
porate their membrane into the surfacemembrane of neutrophils
in response to chemotactic peptides (Borregaard et al., 1987)
and are fully integrated into the surface during transendothelial
migration of neutrophils (Sengeløv et al., 1995). A complete char-
acterization of the protein content of secretory vesicles has not
yet been performed.Control of Granule Exocytosis
Although the structural heterogeneity of neutrophils granules can
be seen and understood as a consequence of differences in
expression of granule proteins duringmaturation of myeloid cells
in the bone marrow, it is less apparent how the hierarchy for
mobilization of neutrophils granules is established. Secretory
vesicles are mobilized completely by several stimuli that are
relevant in the interaction of neutrophils with activated endothe-
lium, such as signaling by selectins and their cognate proteins,
and by chemokines, such as IL-8 and fMLP. In this way, the
secretory vesicles can furnish the surfacemembrane with recep-
tors and other functional proteins, such as integrins, for use in660 Immunity 33, November 24, 2010 ª2010 Elsevier Inc.transmigration without liberating potential harmful granule
proteins (Borregaard et al., 1992, 1993, 1994; Sengeløv et al.,
1993). Gelatinase granules have a somewhat higher threshold
for exocytosis than secretory vesicles (20% mobilized by fMLP
(Kjeldsen et al., 1992, 1993), specific granules again have
a higher threshold than gelatinase granules and azurophil
granules can only be mobilized partially (Sengeløv et al., 1993;
Faurschou et al., 2002).
Neutrophil-Endothelial Cell Interactions
The neutrophils need to cross the vascular wall to arrive at the
site of entry of microorganisms (Figure 2). The crossing takes
place largely at postcapillary venules. Here, the vessel wall is
rather thin, and the diameter of the vessel is sufficiently small
that the neutrophils can make contact with the vessel wall, but
sufficiently large not to be occluded by neutrophils when they
arrest and make firm contact with the endothelium. Leukocyte
recruitment into many systemic organs is unique, and it is not
possible to review this herein. The issue is the subject of several
excellent reviews (Vestweber, 2007; Zarbock and Ley, 2009a,
2009b; Alcaide et al., 2009; Woodfin et al., 2010; Fernandez-
Borja et al., 2010; Petri et al., 2008; Engelhardt, 2008). Themech-
anism for diapedesis of neutrophils described in the following
pertains to neutrophil transendothelial migration in response to
inflammation in the systemic vascular bed.
Rolling
Initial attachment of neutrophils to endothelial cells is determined
by the endothelial cells, which react to stimuli such as TNFa,
IL-1b, and IL-17 that are generated during infection or inflamma-
tion. Such stimulation results in expression of P-selectin (also
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of the integrin superfamily (the ICAMs and VCAMs, detailed later)
on their luminal surface. These selectins bind PSGL-1 (P-selectin
ligand 1) and L-selectin, which are expressed constitutively on
the tips of neutrophil microvilli, a location organized by the ERM
proteins ezrin, radixin, andmoesin that connect to the actin cyto-
skeleton (Bruehl et al., 1997; Steegmaier et al., 1997; Buscher
et al., 2010). E-selectin also binds ESL-1 (E-selectin ligand 1)
present on the side of microvilli and CD44 present on the cell
body (Buscher et al., 2010). Binding of PSGL-1 to P-selectin
andE-selectin establishes the initial contact between neutrophils
and activated endothelial cells. E-selectin and ESL-1mediate the
slower rolling, while E-selectin binding to CD44mediates a redis-
tribution of PSGL-1 and L-selectin to form clusters (Hidalgo et al.,
2007) concomitant with further reduction in the speed of rolling.
The selectin mediated bonds form and detach sequentially, but
sufficient strength to mediate attachment only develops during
the shear stress that is created by the laminar flow of blood in
vessels (Ley et al., 2007; Pospieszalska and Ley, 2009).
Selectins bind sialyl Lewis X carbohydrate structures
expressed on their ligands (Somers et al., 2000). Inherited
defects in intracellular fucose transport disabling the construc-
tion of Lewis X result in leukocyte adhesion deficiency type II
(LAD II) (Lu¨hn et al., 2001; Phillips et al., 1995). The signaling
induced by binding of ligands to PSGL-1 and CD44 involves acti-
vation of Src family kinases Hck, Fgr, and Lyn (Yago et al., 2010),
which phosphorylate and activate ITAMs (immunoreceptor tyro-
sine-based activation motifs) on two adaptor proteins, DAP12
(NDAX activation protein of 12 kDa) and FcRg (g chain of immu-
noglobulin Fc receptors) (Zarbock et al., 2008). These recruit Syk
(spleen tyrosine kinase) that becomes activated by phosphoryla-
tion. Activated Syk in turn activates Bruton tyrosine kinase (Yago
et al., 2010; Mueller et al., 2010), which mediates the further
activation of PLC-g (phospholipase C g), PI3K (Phosphoinositide
3-kinase), and p38 mitogen-activated protein kinase, resulting in
integrin activation and cytoskeletal rearrangements in the
neutrophil (Ley et al., 2007; Woodfin et al., 2010; Barreiro and
Sa´nchez-Madrid, 2009; Scheiermann et al., 2010).
Firm Adhesion
The key molecules mediating firm adhesion of neutrophils to the
activated endothelium are the b2 integrins LAF-1 (aLb2) and
Mac-1 (aMb2), present on neutrophils, and their ligands,
members of the immunoglobulin superfamily, ICAM-1 (intercel-
lular adhesionmolecule-1) and ICAM-2, present on the endothe-
lial cells. Deficiency of CD18 the b2-integrin chain causes
Leukocyt Adhesion Deficiency type I, characterized by inability
to establish firm adhesion and diapedesis of neutrophils (Bunting
et al., 2002).
Integrins can adopt three states of activation: a bent form
incapable of ligand binding, an extended, but not fully open,
form with intermediate ligand binding capacity, and an extended
and open form with full avidity for ligand binding. The molecular
mechanism of integrin activation has been delineated in great
detail and recently reviewed (Evans et al., 2009; Abram and
Lowell, 2009b). Activated phospholipase Cg causes production
of diacyl glycerol, which activates protein kinase C and inositol-
3-phosphate that induces a rise in intracellular Ca2+. These acti-
vate the guanine exchange factor CalDAG-GEF1, which turns thesmall GTPase, Rap-1, into its active GTP associated form. Acti-
vated Rap-1 binds Rap-1-mediated adaptor molecule (RIAM),
which recruits talins to break salt bridges between the cyto-
plasmic tails of the integrin b and a chains by binding to a trans-
membrane-near phosphotyrosine domain, NPxY, in the b chains,
thus twisting the two integrin chains apart. This results in exten-
sion of the extracellular domains and opening for ligand binding
(Anthis et al., 2009). At the same time, talins tether the integrins
to the actin cytoskeleton. Kindlins, like talins, contain domains
for binding to NPxY sites. Kindlin3, which is expressed exclu-
sively in cells of hematopoietic origin, is recruited to the integrin
b chains, but at more distal NxxY sites. Kindlin 3 gene-targeted
mice display defective integrin activation (Moser et al., 2008,
2009a, 2009b) Mutations of kindlin 3 were recently discovered
as cause of congenital leukocyte adhesion deficiency LAD III. In
contrast to LAD I, LAD III also displays hemostatic defects
because of dysfunctional platelets as result of defective activa-
tion of all b integrins (McDowall et al., 2003, 2010; Kuijpers
et al., 2009; Svensson et al., 2009).
LFA-1 is the principal adhesion molecule on neutrophils that
mediates transition from rolling to adhesion on the endothelial
cell surface (Phillipson et al., 2006). Rolling on E- or P-selectin
induces the extended, but not high affinity form of LFA-1
(Kuwano et al., 2010), enabling the LFA-1 to mediate rolling,
but not firm adhesion, to ICAM-1. This activation of LFA-1 is
induced by signals from PSGL-1 and CD44 (Zarbock et al.,
2008; Yago et al., 2010). Full LFA-1 activation is mediated by
activation of the chemokine receptors on neutrophils (Zarbock
et al., 2007), which pick up ligands secreted by endothelial cells
or presented by the endothelial cell glycosaminoglycans or by
the Duffy antigen-receptor for chemokines as discussed in Mid-
dleton et al. (2002) and Zarbock and Ley (2009a). Fully activated
LFA-1 mediates stop of rolling and firm adhesion together with
Mac-1 (Woodfin et al., 2010).
The activated (by tumor-necrosis factor a [TNFa], Interleukin-1
[IL-1], and IL-17) endothelial cells produce IL-8 and MIP-2 that
activate neutrophils. Macrophage migration inhibitory factor
generation by endothelial cells has been shown to enhance the
production of IL-8, P-Selectin, and ICAM-1 by cultured TNFa
stimulated HUVECS (Cheng et al., 2010).
Concomitant with cessation of rolling and induction of firm
adhesion, the neutrophils polarize into a leading edge lamellipo-
dium, where receptors for chemokines and for phagocytosis are
concentrated. This is organized by F-actin and controlled by Gi
type G protein-coupled receptors via signals from phosphoino-
sitol 3 phosphate (PIP3) and the Rho GTPase, Rac. The tail end
of polarized neutrophils contains a contractile actomyosin
system controlled by Ga12 and Ga13 type G protein coupled
receptors, CDC42, Rho A, Rho-dependent kinase, ROCK, and
myosin II (Xu et al., 2003; Van Keymeulen et al., 2006). This
polarization is regulated by Ly49Q, an ITIM (immunoreceptor
tyrosine-based inhibitory motif)-containing receptor, which,
when located in the surface membrane, recruits the phosphotyr-
osine phosphatase SHP1 and maintains the neutrophil round
and suppresses activation but, when active, recruits SHP2 and
reorganizes lipid rafts and their associated signaling molecules
to the perinuclear region and induces the polarized shape via
the signaling molecules mentioned above (Sasawatari et al.,
2010).Immunity 33, November 24, 2010 ª2010 Elsevier Inc. 661
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Once firm adhesion is established, two roads can be taken for
transendothelial migration: the transcellular road, whereby
neutrophils penetrate the individual endothelial cell, or the para-
cellular road, whereby neutrophils squeeze between endothelial
cells. The key players involved in guidance toward paracellular
or transcellular migration are again the major neutrophil b2 integ-
rins LFA-1 and Mac-1 and their ligands ICAM-1 and ICAM-2.
ICAM-1 is concentrated to the recently described tetraspanin-
enriched microdomains to form so-called endothelial adhesive
platforms (Barreiro et al., 2008). This is independent on the cyto-
skeleton and independent on activation of ICAM-1. Binding to
LFA-1 on neutrophils generates signals from the cytoplasmic
tail of ICAM-1 (Fernandez-Borja et al., 2010; van Buul et al.,
2010a). These induce activation of the GTPases RhoG and
RhoA and induce actin polymerization (van Buul et al., 2010a),
leading to formation of small membrane protrusions called apical
cups or docking structures where ICAM-1, and VCAM-1 (a ligand
for b1 integrins) are concentrated (van Buul et al., 2007; Barreiro
et al., 2002), most likely via ezrin, radixin, and moesin that,
when activated, tether ICAM-1 and V-CAM-1 to the actin cyto-
skeleton (Sato et al., 1992; Tsukita and Yonemura, 1997, 1999;
van Buul et al., 2007; Oh et al., 2007). Accumulation of ICAM-1
may by itself recruit VCAM-1 to the clusters (van Buul et al.,
2010b). Tyrosine phosphorylation of cortactin by Src further
enhances the ICAM-1F-actin association andhelps transforming
adhesion platforms to adhesion cups (Yang et al., 2006a, 2006b).
a-actinins recruited to ICAM-1 cytoplasmic tail domains further
strengthen the ICAM-1 F-actin interaction and stabilize the latter
(Yang et al., 2006a; Celli et al., 2006). These cups are necessary
for efficient transcellular migration both via the transcellular route
and via the paracellular route (Carman and Springer, 2004).
ICAM-2 and PECAM-1 are concentrated at endothelial cell junc-
tions (Woodfin et al., 2009). a9b1 is the major b1 integrin upregu-
lated on (human) neutrophils by recruitment from intracellular
stores not yet identified (Mambole et al., 2010). This allows adhe-
sion to VCAM-1 (Taooka et al., 1999; Mambole et al., 2010) but
plays a minor role in neutrophil transendothelial migration
compared to LFA-1 and Mac-1 (Woodfin et al., 2010).
Mac-1, the other major b2 integrin on neutrophils, mediates
crawling of neutrophils along endothelial cells to points of para-
cellular migration (Phillipson et al., 2006; Woodfin et al., 2010).
Mac-1 interacts to a large extent with the same ligands on endo-
thelial cells as LFA-1, i.e., ICAM-1 and ICAM-2. Vav1, a guanine
exchange factor and activator for the Rho family GTPases, Rac
and Cdc42, which are central for downstream signaling from
LFA-1, is essential for this active migration of neutrophils toward
endothelial cell-cell borders mediated by Mac-1 as observed
in vivo during flow (mouse cremaster) (Phillipson et al., 2009).
It was recently suggested that stimulated neutrophils release
a truncated form of the cytosolic protein annexin A1, lacking
the N-terminal 26 amino acids as result of proteolysis by calpain.
This 33 kDa peptide activates endothelial cells via extracellular
signal regulated kinase (ERK1 and 2) to support transendothelial
cell migration as demonstrated in vitro in a trans-well system
using confluent HUVECs (human umbilical vene endothelial cells)
(Williams et al., 2010).
The molecular mechanisms mediating the paracellular migra-
tion of neutrophils have beenworked out in great detail. Themain662 Immunity 33, November 24, 2010 ª2010 Elsevier Inc.players on endothelial cells are ICAM-1; ICAM-2; PECAM-1
(platelet endothelial cell adhesion molecule 1); JAM (junctional
adhesionmolecule)-A, -B, and -C; ESAM (endothelial cell-selec-
tive adhesionmolecule); PVR (poliovirus receptor—all belonging
to the immunoglobulin superfamily—CD99; CD99L2; and
VE-Cadherin. PECAM-1; JAM A, -B, and -C; ESAM; CD99; and
VE-cadherins form homotypic contacts to stabilize the endothe-
lial cell junctions, but with the exception of VE-cadherin and
ESAM, these adhesion molecules are also expressed on the
neutrophil (PECAM-1, JAM A, CD99) and are capable of binding
to proteins expressed on the neutrophil surface and, thus, assist
the neutrophils in passage between the endothelial cells.
The following sequence has been demonstrated: ICAM-1 and
ICAM-2 accumulate at the cell-cell junctions mediating neutro-
phil contact via their b2 integrin partners (LFA-1 and Mac-1).
ICAM-1 at the endothelial cell junctions guides neutrophils to
these structures (Alcaide et al., 2009). Signals from ICAM-1
activate Src and Pyk-2 tyrosine kinases, which phosphorylate
VE-Cadherin and destabilize the VE-Cadherin bonds, probably
by preventing VE-Cadherin from associating with b-catenin
that mediates binding to the actin cytoskeleton via a-catenin
(van Buul et al., 2005, 2010a; van Buul and Hordijk, 2008; Alling-
ham et al., 2007), thus loosening the endothelial cell-cell junc-
tions. ESAM may also play a role in loosening of the endothelial
cell junctions. Lack of ESAM, as demonstrated in the Esam/
mouse, results in decreased activity of the Rho signaling
pathway in endothelial cells (Wegmann et al., 2006), which is
known to destabilize endothelial cell junctions (Stamatovic
et al., 2003). Lack of ESAM results in decreased neutrophil trans-
endothelial cell migration as observed in both the mouse
cremaster model (Wegmann et al., 2006) and in an ischemia
reperfusion mouse liver model (Khandoga et al., 2009).
ICAM-2 concentrated at the endothelial cell junctions further
guides neutrophils to enter the endothelial cell junctions. Neutro-
phils accumulate at the entrance between endothelial cells if
ICAM-2 is blocked or absent and successful transmigration is
inhibited correspondingly (Woodfin et al., 2009).
Further penetration between the cells is mediated by JAM-A
as neutrophils accumulate deeper down between the endothelial
in Jama/ mice than in Icam2/ mice as observed in vivo in
IL-1b stimulated mouse cremaster muscle endothelial cells.
Finally, neutrophils are observed to accumulate between the
endothelial cells and the basement membrane in Pecam1/
mice, indicating that PECAM-1 is essential for the neutrophils
to slide through this compartment (Woodfin et al., 2009). Upre-
gulation of the laminin receptor a6b1 induced by PECAM-1
signaling assists the further migration through the perivascular
basement membrane (Dangerfield et al., 2002). Endothelial cell
PECAM-1may also interact with the GPI-linked CD177 (NB1-an-
tigen), which is upregulated on neutrophil surfaces from specific
granules to facilitate transmigration (Sachs et al., 2007). The
CD177-PECAM-1 interaction facilitates neutrophil transmigra-
tion with an efficacy that depends on a dimorphism of the
PECAM-1 antigen (Bayat et al., 2010).
CD99 and the distantly related CD99L2 are both small, approx.
100 amino acid long, but highly O-glycosylated proteins. They
are both expressed at endothelial cell-cell junctions and on
leukocytes including neutrophils (Bixel et al., 2010). Both induce
cell-cell aggregation (Dufour et al., 2008; Bixel et al., 2007, 2010),
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antibodies in in vivo studies (Bixel et al., 2007; Dufour et al.,
2008). Blocking antibodies against CD99 and CD99L2 lead to
neutrophil accumulation between the endothelial cells and the
basement membrane, similar to the stop in diapedesis observed
in the absence of PECAM-1 (Bixel et al., 2010).
As mentioned before, the neutrophils may exploit these mole-
cules, which form part of the endothelial cell-cell junction by
providing alternative homotypic binding because these
molecules are also expressed on the activated neutrophil. This
mechanism is demonstrated by the deficient transendothelial
migration and accumulation of JAM-A-deficient neutrophils
between endothelial cells that express JAM-A (Corada et al.,
2005). In addition, LFA-1 can bind to JAM-A at a site distant
from the site for homotypic interaction and, by doing so, loosen
the homotypic binding (Wojcikiewicz et al., 2009). JAM-A may
also be shed from the activated endothelial cells by ADAM17,
and soluble JAM-A bound to LFA-1 on the neutrophils can inhibit
transcellular migration in such negative feedback (Koenen et al.,
2009).
The transcellular route is believed to be taken by some 20% of
neutrophils but may vary greatly among different tissues and
depend on the stimulation of the endothelial cells in in vitro
set-ups (Woodfin et al., 2010). It seems that the lateral migration
of neutrophils mediated by Mac-1 favors paracellular migration,
and trancellular migration increases from 20% to 80% in the
absence of Mac-1 as determined in a mouse cremaster muscle
preparation (Phillipson et al., 2008). In that study, the endothelial
cell docking structureswere demonstrated to progress to domes
that finally swept around the neutrophil in a process similar to
phagocytosis, thus indicating a very active role of the endothelial
cell in transcellular migration. An active role for the transmigrat-
ing cell has also been proposed. Podosome-like protrusions
were described on lymphocytes that serve as probes for seeking
out areas on the endothelial cell where transcellular migration
would be favorable (Carman, 2009; Carman et al., 2007).
Because ICAM-2, PECAM-1, and JAM-A, which are important
for paracellular migration, are localized to the endothelial cell
junctions, other proteins must be involved in guiding the cell
across the endothelial cell body. It has been suggested that
SNARE proteins essential in trafficking and fusion of intracellular
organelles and exocytosis of granules and vesicles are essential
in this process (Carman et al., 2007).
After crossing the endothelial lining, neutrophils must make
their way through the basal membrane. The neutrophil is
highly equipped with proteases capable of breaking down the
basal membrane collagens and laminins such as elastase
(azurophil granules), MMP8 (specific granules), MMP9, and
the membrane attached matrix metalloproteinase MT6-MMP
(gelatinase granules and secretory vesicles) (Kang et al., 2001).
Evidence that these proteases are essential for neutrophil
transendothelial migration is scarce, as only minimal effects
are observed in gene-targeted mice and in studies using specific
protease inhibitors (Kolaczkowska et al., 2009). It is possible
that the same retraction of endothelial cells that opens the tight
junctions subsequently allows passage through the basal
membranes of a cell, capable of amoeboid migration, such as
the neutrophil, without necessitating degradation of the matrix
(Rowe and Weiss, 2008).Tissue Neutrophils
Neutrophils that have migrated into tissues are more active as
phagocytic cells than blood neutrophils (Sørensen et al., 2001)
and activate a transcriptional program that results in generation
of several chemokines, including IL-8 and Groa (Theilgaard-
Mo¨nch et al., 2004; Scapini et al., 2000, 2005), that recruit
additional inflammatory cells. The initiating factor(s) responsible
for this wave of transcriptional activity is not known, but local
production of G-CSFmay be important as indicated by its induc-
tion of synthesis and secretion of B-lymphocyte stimulator (BlyS)
(Scapini et al., 2005, 2008) in neutrophil exudates. Also, engage-
ment of the triggering receptor expressed on myeloid cells
(TREM-1) (by ligands not yet identified; Ford and McVicar,
2009), which is upregulated (Bouchon et al., 2000, 2001) and
signals through DAP12 (presented earlier) (Bouchon et al.,
2000; Tessarz and Cerwenka, 2008), may lead to degranulation
and transcriptional activity (Bouchon et al., 2000).
Activation of neutrophil respiratory burst and mechanisms of
microbial killing have been reviewed recently (El-Benna et al.,
2009; Robinson, 2008, 2009; Holland, 2010; Nauseef, 2007;
Flannagan et al., 2009). It should be mentioned that a function
was recently identified for the 3rd cytosolic component,
p40phox, which assembles with the other two cytosolic compo-
nents, p47phox and p67phox, and the membrane bound p22phox,
gp91phox complex to form the NADPH oxidase. P40phox is neces-
sary for assembly of the NADPH oxidase on intracellular
membranes, including phagosomes into which the p22phox,
gp91phox bearing granules fuse, and deficiency of p40phox results
in partial NADPH oxidase deficiency (Matute et al., 2009).
Whereas the presence of fully functional neutrophils in tissues
is absolutely critical for our defense against microbial infections,
as testified by the immunodeficiency associated with LAD
(Abram and Lowell, 2009a; Abram and Lowell, 2009b; Bunting
et al., 2002) and chronic granulomatous disease (Holland,
2010), it is equally important that the influx of neutrophils is
controlled to prevent neutrophil-mediated tissue damage. This
is controlled by negative feedback at several stages.
Intracellular negative feedback is provided by proteins
carrying immunoreceptor tyrosine-based inhibitory motifs
(ITIMs), which recruit phosphotyrosine phosphatases to deacti-
vate receptors that are kept in signaling mode by phoshotyro-
sines (Dae¨ron et al., 2008). Signal Inhibitory Receptor on Leuko-
cytes-1 (Steevels et al., 2010), CEACAM1, and CD300a contain
ITIMs of which the latter two are mobilized to the surface of
neutrophils during activation (Ducker and Skubitz, 1992; Alvarez
et al., 2008; Skubitz and Skubitz, 2008). Similarly, SOCS-3
(suppressor of cytokine signaling 3) downregulates G-CSF
receptor signaling by blocking the phosphotyrosine on the acti-
vated receptor and preventing its interaction with STAT3 (signal
transducer and activator of transcription 3), necessary for
further signaling. The importance of this regulation is illustrated
by the hyperactive neutrophils in SOCS3-deficient mice (Croker
et al., 2004). MicroRNAs also regulate neutrophil activity. MiR-
223 gene-targeted mice have hyperresponsive neutrophils that
infiltrate organs and inflict tissue damage both spontaneously
and after LPS stimulation (Johnnidis et al., 2008). MiR-9 is
induced in LPS and TNF-a-stimulated neutrophils by NF-kB
and exerts a feedback inhibition on NF-kB translation (Bazzoni
et al., 2009).Immunity 33, November 24, 2010 ª2010 Elsevier Inc. 663
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resolve inflammation operating at several stages has been iden-
tified after the deorphanization of theG protein-coupled receptor
ChemR23 expressed on macrophages, dendritic cells, and
recently also by activated endothelial cells (Kaur et al., 2010).
Chem R23 was identified as receptor for chemerin, a 16 kD
protein synthesized primarily by the liver. C-terminal peptides
derived from chemerin are powerful agonists of ChemR23 and
may be generated by proteolytic processing mediated by
neutrophil proteases (Zabel et al., 2005, 2006). ChemR23 medi-
ates a nonphlogistic activation of macrophages via PI3-K, Akt,
and Syk signaling that greatly enhances the phagocytic capacity
of macrophages, not the least for uptake of apoptotic neutrophils
(Ohira et al., 2010; Cash et al., 2010). This reduces the risk of
necrotic neutrophil death and also downregulates the production
of G-CSF to limit neutrophil activation locally and release from
the bone marrow as discussed previously.
A systemic analysis of lipid mediators generated in exudates
identified two unique classes of anti-inflammatory lipid media-
tors, the resolvins and the protectins, both products generated
from u-3 fatty acids (Schwab et al., 2007; Serhan et al., 2008;
Serhan, 2009). Resolvin E1 activates the ChemR23 and inhibits
proinflammatory responses in macrophages (Ishida et al.,
2010) and blocks the LTB4 receptor BLT1, thus inhibiting LTB4-
mediated activation of neutrophils (Arita et al., 2007) and the
neutrophil-induced increase in vascular permeability (Di Gen-
naro et al., 2009). Resolvin D1, which like resolvin E1 is also
generated at the resolution phase of inflammation, activates
the lipoxin A4 receptor, ALX, known to mediate the anti-inflam-
matory actions of lipoxin A4 (Maderna and Godson, 2009; Dufton
et al., 2010; Maderna et al., 2010) and ChemR32. Like resolvin
E1, resolvin D1 inhibits neutrophil activation (actin polymeriza-
tion and b2-integrin activation) (Serhan et al., 2008). Resolvin
D2 has recently been shown to inhibit neutrophil activation and
to augment the generation of nitric oxide by endothelial cells
(Spite et al., 2009). In the same study, Resolvin D2 inhibited
the adherence of neutrophils to activated endothelial cells in
a mouse cremaster model. This was dependent of the induction
of nitric oxide generation in accordance with the ability of nitric
oxide to reduce neutrophil adherence to endothelial cells (Kubes
et al., 1991). Recently, pentraxin 3, which is liberated from
specific granules during transendothelial migration, has been
shown to bind to P-selectin on endothelial cells and block its
ability to capture neutrophils, thus serving as a narrow-looped
negative feedback for neutrophil transmigration (Deban et al.,
2010).
Neutrophil Extracellular Traps
During the last 6 years, it has been clear that neutrophils may
extend their antimicrobial activity beyond life of the neutrophil.
Formation of neutrophil extracellular traps (NETs) is an alternative
to death by necrosis or apoptosis. During netosis, the nuclei swell
and the chromatin is dissolved. Large strands of decondensed
DNAare extruded from the cell, carrying alongwith themproteins
fromcytosol, fromgranules (which also disintegrated at the same
time as the nuclei dissolve), and fromchromatin (histones) (Brink-
mann and Zychlinsky, 2007; Brinkmann et al., 2004; Fuchs et al.,
2007). Mass spectrometry has identified 24 neutrophil proteins
associated with NETs (Urban et al., 2009). NET proteins are664 Immunity 33, November 24, 2010 ª2010 Elsevier Inc.primarily the cationic (thus, DNA-binding) bactericidal proteins:
histones, defensins, elastase, proteinase 3, heparin binding
protein, cathepsin G, lactoferrin, and myeloperoxidase (Urban
et al., 2009), but also the pattern recognition molecule Pentraxin
3, is NET associated (Jaillon et al., 2007). Notably, the S100A8,9
complex known as calprotectin that constitutes 40% of the
neutrophil’s cytosolic protein (Murthy et al., 1993) is a prominent
NET component and confers NETs with the ability to kill Candida
species (Urban et al., 2009) and to impair growth of Aspergillus
fumigates (McCormick et al., 2010).
The mechanism for formation of NETs is not yet completely
known. Decondensation of chromatin, which is particularly
dense in mature neutrophils, is associated with citrullination of
Histone H3 by conversions of histone arginine to citrulline
residues by peptidylarginine deiminase 4 (PAD4) (Wang et al.,
2004), an enzyme which is particularly rich in mature neutrophils
(Nakashima et al., 2002). This process seems central for NET
formation because mice deficient in PAD4 fail to form NETs,
and NET-dependent bacterial killing in vitro is correspondingly
reduced. More important, the PAD4-deficient mice are more
susceptible to necrotizing fasciitis induced by group A Staphylo-
cocci than wild-typemice (Li et al., 2010). Elastase released from
azurophil granules degrades histones and synergize with myelo-
peroxidase to drive chromatin decondensation essential for NET
formation (Papayannopoulos et al., 2010). NET formation is
dependent on hydrogen peroxide generated by the NADPH
oxidase and further metabolized by myeloperoxidase. CGD
neutrophils and MPO-deficient neutrophils, therefore, do not
form NETs (Bianchi et al., 2009; Metzler et al., 2010). Nitric oxide
was recently demonstrated to induce NETs in a process that was
dependent on myeloperoxidase, but the active species were not
identified (Patel et al., 2010). Neutrophils from normal newborns
are partly deficient in NET production, despite full respiratory
burst activity, and demonstrate decreased extracellular bacteri-
cidal activity (Yost et al., 2009). The mechanism for this defi-
ciency is unknown.
It was recently suggested that extracellular strands of DNA
may also be generated from mitochondria from activated
neutrophils in a process that was compatible with full neutrophil
activity after NET formation, thus indicating an alternative to NET
formation as a death mechanism of neutrophils (Yousefi et al.,
2009).
NETs are cleared by DNases. Systemic lupus erythematosis
(SLE) patients have autoantibodies against DNA-associated
proteins such as the components of NETs. A subset of patients
were recently identified with decreased activity of DNase-1,
which is a NET-degrading protein found in plasma (Hakkim
et al., 2010). These patients had enhanced risk of nephritis. Along
the same lines, NETs were shown to induce thrombosis by stim-
ulating platelets in vitro, and NET components were abundant in
thrombi induced in a baboon model (Fuchs et al., 2010). NETs
were recently found to damage activated human endothelial
cells in culture (Gupta et al., 2010), all pointing to a potential
proinflammatory role of NETs. The full contribution of NETs to
overall antimicrobial activity versus the classical microbicidal
activity of phagocytosing neutrophils in vivo has not yet been
established. NETs may provide the biological basis for the old
classification of pus into the viscous ‘‘pus bonum,’’ i.e., the
good pus (NETs), and the liquid ‘‘pus malle,’’ i.e., the bad pus
Immunity
Review(no NETs), known to be predictive of good and poor outcome
of infections in the preantibiotic era.
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